Remission achievable with usual care for axial spondyloarthritis
For patients with axial spondyloarthritis (axSpA), remission is attainable with usual care, according to a study published in the Journal of Rheumatology.
18 hours ago
0
5
Musculoskeletal Diseases: News and Research on Arthritis
MeSH tree: C05.550.114
Patient-reported outcomes worse for patients with rheumatoid arthritis discontinuing TNF inhibitor
For patients with rheumatoid arthritis (RA), patient-reported outcomes (PROs) generally worsen shortly after tumor necrosis factor inhibitor (TNFi) discontinuation, according to a study published in the Journal of Rheumatology.
18 hours ago
0
4
Increased risk for long COVID associated with autoimmune rheumatic diseases
Patients with autoimmune rheumatic diseases (AIRD) have an increased risk for long COVID, according to a study published online Oct. 14 in Arthritis & Rheumatology.
Oct 20, 2026
0
25
How psychological stress can trigger arthritis flares via an inflammatory pathway
Psychological stress has long been associated with worsening symptoms in rheumatoid arthritis (RA). However, the underlying mechanism connecting psychological stress to the occurrence of joint inflammation has remained poorly ...
Oct 16, 2026
0
257
Opioids only useful for short-term pain relief, study finds
Researchers from the University of Alberta have found that opioids are best used for acute pain relief for four weeks or less and may cause more harm than good when used for chronic pain for more than 12 weeks.
Oct 14, 2026
0
11
Drug tapering noninferior to treatment continuation for rheumatoid arthritis with low disease activity
For patients with rheumatoid arthritis (RA) with sustained low disease activity (LDA), structured tapering of biologic or targeted synthetic disease-modifying antirheumatic drugs (b/tsDMARDs) is noninferior to treatment continuation ...
Oct 13, 2026
0
5
Nearly one billion people could live with osteoarthritis by 2050, international experts warn
Almost 1 billion people are projected to be living with osteoarthritis by 2050, up from about 600 million in 2023, and there remains no cure and no drug that can stop or slow the disease, according to a new roadmap published ...
Oct 12, 2026
0
5
Pausing certain arthritis drugs after COVID-19 vaccination raises flare risk without improving antibody response
For patients with inflammatory arthritis, holding certain disease-modifying antirheumatic drugs (DMARDs), namely select biologic or Janus kinase inhibitor (JAKi) therapies, for two weeks at the time of a supplemental COVID-19 ...
Oct 6, 2026
0
11
High blood pressure can accelerate osteoarthritis joint damage via a newly identified hormone pathway
For millions of people, osteoarthritis slowly breaks down the joints, bringing pain, swelling and stiffness that make free movement harder with time. It is largely a condition of age, with 73% of those living with it older ...
Exercise as medicine—how exercise protects joints in aging-related osteoarthritis
Researchers at Mass General Brigham have found that moderate-intensity exercise alters circulating extracellular vesicles in ways that promote cartilage health and tissue resilience, identifying microRNA-29 as a key mediator ...
Sep 29, 2026
0
89
